Any current/future new fundraising through debt or equity?

The company is funding current projects through a mix of debt and internal accruals. A new project funding proposition is being worked out and will be shared at an appropriate time. The company has a strong balance sheet with continuing cash generation of around Rs. 1,000 crores per annum. There is no explicit mention of any immediate or planned equity fundraising in the transcript. Focus is on executing ongoing capex projects largely funded internally or by debt. Overall, any future fundraising plans, either debt or equity, are not detailed but will be communicated when decided.

Any current/future capex/capital investment/strategic investment?

Rs. 14,000 crores investment announced for multiple projects including new phenol and acetone plant, downstream BPA, and a 200 KT aniline plant. Ongoing projects worth around Rs. 2,000 crores in final stages of implementation, commissioning in current financial year. Includes MIBK, MIBC, nitric acid, enhanced nitration, hydrogenation, and specialty chemicals. FY25 planned capex of about Rs. 1,200 crores; excludes polycarbonate compounding project. Separate polycarbonate compounding pilot plant (30,000 tonnes/year) being set up, fungible and aimed at customer validation; large-scale compounding

Future growth expectations in sales/revenue/volumes?

Early indicators of increased volume and improved customer sentiment observed in Q1 FY25. Short-term guidance anticipates a meaningful recovery starting from the latter part of Q3 FY25. Domestic market shows high industrial activity with healthy demand levels; volume growth noted (5% overall growth in Advanced Intermediates). Anticipation of higher demand and stronger product realizations by year-end FY25. Continued volume recovery expected in most products except a few agrochemicals still soft. New product launches and expanded capacity (e.g., 18-20% increase in DASDA and OBA) support growth.

Future growth expectations in earnings/operating earnings/profits/EPS?

Deepak Nitrite anticipates a meaningful recovery in earnings and operating profits starting from the latter part of Q3 FY25 despite ongoing pricing pressures and industry challenges. The company projects double-digit growth supported by volume improvement, enhanced customer sentiment, and operational efficiencies. EBITDA and EBIT margins are expected to improve as expansion and debottlenecking projects complete, including downstream phenol, BPA, and polycarbonate plants. FY25 capex of Rs. 1,200-2,000 crores focuses on projects that will enhance capacities and integration, with larger projects

Deepak Nitrite LtdQ1 FY25Chemicals & Petrochemicals

Deepak Nitrite Ltd Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,446.8P/E: 24.9Market Cap: ₹19.7K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

Early indicators of increased volume and improved customer sentiment observed in Q1 FY25.
Short-term guidance anticipates a meaningful recovery starting from the latter part of Q3 FY25.
Domestic market shows high industrial activity with healthy demand levels; volume growth noted (5% overall growth in Advanced Intermediates).
Anticipation of higher demand and stronger product realizations by year-end FY25.
Continued volume recovery expected in most products except a few agrochemicals still soft.
New product launches and expanded capacity (e.g., 18-20% increase in DASDA and OBA) support growth.
Export volumes face pricing pressure due to China destocking, but domestic volumes are growing.
FY24-25 marks the start of a transformative journey with key projects and R&D investments to bolster growth.
Company focusing on expanding in specialty chemicals and engineering application chemicals alongside commodity segments.

Margin guidance

Category 3

Deepak Nitrite anticipates a meaningful recovery in earnings and operating profits starting from the latter part of Q3 FY25 despite ongoing pricing pressures and industry challenges.
The company projects double-digit growth supported by volume improvement, enhanced customer sentiment, and operational efficiencies.
EBITDA and EBIT margins are expected to improve as expansion and debottlenecking projects complete, including downstream phenol, BPA, and polycarbonate plants.
FY25 capex of Rs. 1,200-2,000 crores focuses on projects that will enhance capacities and integration, with larger projects slated for FY26 onwards.
Sustained demand in phenolics and improving domestic volumes in advanced intermediates support growth.
Efficiency initiatives and sustainability efforts underpin long-term margin expansion.
The company targets growth driven by expanding product portfolio and market penetration, with focus on specialty chemicals and building blocks.
Management remains optimistic about the medium-term earnings trajectory tied to capacity expansions and market conditions stabilizing.

See what Deepak Nitrite Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

The company is funding current projects through a mix of debt and internal accruals.
A new project funding proposition is being worked out and will be shared at an appropriate time.
The company has a strong balance sheet with continuing cash generation of around Rs. 1,000 crores per annum.
There is no explicit mention of any immediate or planned equity fundraising in the transcript.
Focus is on executing ongoing capex projects largely funded internally or by debt.
Overall, any future fundraising plans, either debt or equity, are not detailed but will be communicated when decided.

Order book

The transcript on page 17 (and surrounding pages) does not provide explicit details regarding the current or expected order book or pending orders for Deepak Nitrite Limited. However, some relevant points can be inferred: - The company is executing multiple large projects including specialty chemicals, phenol, BPA, polycarbonate, and advanced intermediates with a capex of around Rs. 14,000 crores. - Rs. 2,000 crores worth of projects are expected to be completed by Q4 FY25, with focus shifting to larger MOUs post that. - The management highlighted strong demand and volume growth in various segments despite pricing pressure and supply chain challenges. - There is mention of cautious but improving customer sentiment and expected recovery from the latter part of Q3 FY25. - No explicit order book figures or pending orders data were disclosed during the call. Thus, while project execution and demand visibility are positive, no quantifiable order book or pending order value is specified.

See what Deepak Nitrite Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Rs. 14,000 crores investment announced for multiple projects including new phenol and acetone plant, downstream BPA, and a 200 KT aniline plant.
Ongoing projects worth around Rs. 2,000 crores in final stages of implementation, commissioning in current financial year. Includes MIBK, MIBC, nitric acid, enhanced nitration, hydrogenation, and specialty chemicals.
FY25 planned capex of about Rs. 1,200 crores; excludes polycarbonate compounding project.
Separate polycarbonate compounding pilot plant (30,000 tonnes/year) being set up, fungible and aimed at customer validation; large-scale compounding capex to follow separately after validation.
Technology tie-ups for large projects expected by year-end; engineering and project execution teams working in stages for smooth rollout.
Past Rs. 2,000 crore capex split roughly 60% upstream integration, 40% downstream (excluding Rs. 300-350 crores in land and infrastructure).
Focus on completing current Rs. 2,000 crore projects by Q4 FY25 and ramping up larger MOUs from FY26 onward.

Track Deepak Nitrite Ltd — get its next earnings analysis in your feed

How does Deepak Nitrite Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisDeepak Nitrite Ltd

Rev 3Mar 3

See where Deepak Nitrite Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Deepak Nitrite Ltd rank in Chemicals & Petrochemicals?

Compare Deepak Nitrite Ltd against every Chemicals & Petrochemicals company (Q1 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Deepak Nitrite Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Fairchem Organic (Q2 FY27)
Q2 FY27 revenue from operations: Rs 1,669 Mn, up 49.7% YoY from Rs 1,115 Mn in Q2 FY26 (Page 16). Key investor presentation takeaways from Fairchem Organic's Q2
SRF Ltd (Q2 FY27)
4,904.20 crores for Q2 FY 2026-27 . Key investor presentation takeaways from SRF Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.
GOCL Corporation Ltd (Q2 FY27)
Year-on-year (YoY) increase in revenue from operations: Approximately 85% increase (41,063 vs. Key results statement takeaways from GOCL Corpn.'s Q2 FY27 result
Bhansali Engineering Polymers Ltd (Q2 FY27)
For Q2 FY27, revenue from operations was ₹403.4 crores, a 24.1% year-on-year (YoY) increase from ₹325.1 crores in Q2 FY26 (Page 28, Page 7). Key investor presen

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Deepak Nitrite Ltd Q1 FY25 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Deepak Nitrite Ltd rank in Chemicals & Petrochemicals?

Continue your research

What Deepak Nitrite Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season